Retatrutide and Hepatic Lipid Research: Detailed Review of Phase 2 and Preclinical Findings
Hepatic lipid metabolism remains one of the most critical frontiers in metabolic research, with implications for understanding metabolic dysfunction-associated steatotic liver disease (MASLD) and related metabolic disorders. Retatrutide has emerged as a particularly significant compound in this research domain, offering investigators a unique tool to study how triple-receptor activation influences liver fat parameters. This comprehensive […]